Skip to content
Original
fda.gov· FDA·· 6 hours agoScore61

Neuroscience Advancement and Innovation Nexus (NAIN)

In brief

FDA has launched the Neuroscience Advancement and Innovation Nexus (NAIN) to strengthen coordination across its medical product centers and advance development of medical products for diseases and conditions affecting the brain and nervous system.

Source: fda.gov · fda.gov

#Regulatory#Neuroscience#FDA
CBACBA Frontier Insights (CFI)Chinese Biopharmaceutical Association (CBA)www.cba-usa.org